I recommend a three-part income strategy: WRB.PR.E baby bond, PSA.PR.H preferred, and CME Group for a blend of yield and growth. WRB.PR.E and PSA.PR.H offers 7%+ yields, trades at discounts, and provides strong credit quality but lacks income growth and inflation protection. CME delivers a 4%+ yield, 8–10% expected EPS growth, and benefits from volatility, offering inflation protection and capital appreciation potential.
WRB's premium growth, higher investment income, and disciplined underwriting could support results, while rising expenses may temper profitability.
Get a deeper insight into the potential performance of W.R. Berkley (WRB) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metrics.
| Insurance Industry | Financials Sector | William Robert Berkley Jr. CEO | LSE Exchange | 084423102 CUSIP |
| US Country | 8,606 Employees | 21 Sep 2026 Last Dividend | 11 Jul 2024 Last Split | 7 Sep 1984 IPO Date |
Founded in 1967 and headquartered in Greenwich, Connecticut, W. R. Berkley Corporation stands as a premier insurance holding entity with a far-reaching influence both in the United States and internationally. The company distinguishes itself in the insurance landscape through its operation in two core segments: Insurance and Reinsurance & Monoline Excess. W. R. Berkley Corporation has built its reputation on providing a comprehensive array of commercial lines coverage, tailoring its offerings to meet the diverse needs of its clients. This includes a profound expertise in underwriting commercial insurance spanning various industries and risk categories, leveraging deep market knowledge to offer specialized insurance solutions. Through its disciplined approach to risk management, combined with an innovative product range, W. R. Berkley Corporation has established a commendable position in providing effective insurance and reinsurance solutions to a global clientele.